Of note, Lende et al. conducted a randomized controlled trial reporting that, in a subgroup of estrogen receptor positive cases, operable BC patients who received oral pre-operative carbohydrates had higher tumor proliferation (determined as the mitotic activity index in the surgical pathology specimen) and poorer relapse-free survival rates in respect to fasting patients [141]. Here, ESR1 is linked to breast cancer.